Seres Therapeutics (MCRB) Reports Q1 Loss of $0.59

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.59), versus ($0.69) reported last year. Revenue for the quarter came in at $7.3 million, versus $3.97 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• MotorK names Roy Toren to board as Helen Protopapas resigns